The above results combined with the results in Tables 4, 6, and 7 infer that inhibiting the expression of both MACC1 and c-Met proteins at the same time is beneficial to prolong the overall survival and progression-free survival of patients with esophageal squamous cell carcinoma. Here, MET is linked to esophageal squamous cell carcinoma.